1. Wu Y, Xue J, Wang C, Li W, Wang L, Chen W, Prabakaran P, Kong D, Jin Y, Hu D, Wang Y, Lei C, Yu D, Tu C, Bardhi A, Sidorov I, Ma L, Goldstein H, Qin C, Lu L, Jiang S, Dimitrov DS, Ying T. Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection. J Virol. 2019 Sep 30;93(20):e01077-19.
2. Shi B, Wu Y, Wang C, Li X, Yu F, Wang B, Yang Z, Li J, Liang M, Wen Y, Ying T, Yuan Z. Evaluation of antiviral - passive - active immunization (sandwich) therapeutic strategy for functional cure of chronic hepatitis B in mice. EBioMedicine. 2019 Nov;49:247-257.
3. Wang L, Xu J, Kong Y, Liang R, Li W, Li J, Lu J, Dimitrov DS, Yu F, Wu Y, Ying T. Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel). 2019 Nov 4;8(4):53.
4. Hu D, Zhu Z, Li S, Deng Y, Wu Y, Zhang N, Puri V, Wang C, Zou P, Lei C, Tian X, Wang Y, Zhao Q, Li W, Prabakaran P, Feng Y, Cardosa J, Qin C, Zhou X, Dimitrov DS, Ying T. A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III. PLoS Pathog. 2019 Jun 26;15(6):e1007836.
5. Wang Y, Hu D, Wu Y, Ying T. Recent advances in universal influenza virus antibodies: the rise of a hidden trimeric interface in hemagglutinin globular head. Front Med. 2020 Apr;14(2):149-159.
6. Tian X, Li C, Huang A, Xia S, Lu S, Shi Z, Lu L, Jiang S, Yang Z, Wu Y, Ying T. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020 Feb 17;9(1):382-385.
7. Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, Gu C, Zhang R, Tu C, Xie Y, Yang Z, Lu L, Jiang S, Ying T. Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020 Jun 10;27(6):891-898.
8. Li Y, Wu H, Chen G, Wei X, Wang C, Zhou S, Huang A, Zhang Z, Zhan C, Wu Y, Ying T. Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models. Front Oncol. 2020 Aug 18;10:1117.
9. Tian X, Li C, Wu Y, Ying T. Deep mining of human antibody repertoires: concepts, methodologies and applications. Small Methods. 2 September 2020 ;4,
2000451.
10. Zhu X, Yu F, Wu Y, Ying T. Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy. Antib Ther. 2021 May 17;4(2):89-98.
11. Li C, Tian X, Jia X, Wan J, Lu L, Jiang S, Lan F, Lu Y, Wu Y, Ying T. The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2. Signal Transduct Target Ther. 2021 Mar 23;6(1):132.
12. Jin Y, Yu D, Tian X, Li H, Zhou X, Kong Y, Zhang W, Zhang L, Lei C, Yang Z, Tu C, Wu Y, Ying T. A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms. Acta Pharmacol Sin. 2021 Jul 7.
13. Wang C, Hong J, Yang Z, Zhou X, Yang Y, Kong Y, Chen B, Wu H, Qian B, Dimitrov DS, Zhou X, Wu Y, Ying T. Design of a Novel Fab‐Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use. Small Methods, 2021.
14. Tian X, Li C, Wu Y, Ying T. Insights into biological therapeutic strategies for COVID-19. Fundamental Research, 2021, 1(2): 166-178.
15. Chen G, Kong Y, Li Y, Huang A, Wang C, Zhou S, Yang Z, Wu Y, Ren J, Ying T. A Promising Intracellular Protein-Degradation Strategy: TRIMbody-Away Technique Based on Nanobody Fragment. Biomolecules. 2021 Oct 14;11(10):1512.
16. Yang Z, Wang Y, Jin Y, Zhu Y, Wu Y, Li C, Kong Y, Song W, Tian X, Zhan W, Huang A, Zhou S, Xia S, Tian X, Peng C, Chen C, Shi Y, Hu G, Du S, Wang Y, Xie Y,Jiang S, Lu L, Sun L, Song Y, Ying T. A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants. Signal Transduct Target Ther. 2021 Nov 3;6(1):378
